Not all new and often expensive cancer medications that hit the market in the past years are proving as effective as hoped in practice. The medicines for some types of cancers seem to increase their patients’ chance of survival, but others seem to have little effect, De Volksrkant reports based on figures from the Netherlands comprehensive cancer center IKNL.